KORU Medical Systems (NASDAQ:KRMD – Get Free Report) had its price target hoisted by analysts at Craig Hallum from $4.00 to $5.00 in a note issued to investors on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. Craig Hallum’s target price suggests a potential upside of 60.77% from the stock’s previous close.
Several other equities research analysts have also recently weighed in on the company. Canaccord Genuity Group upped their price target on KORU Medical Systems from $3.00 to $4.00 and gave the company a “buy” rating in a research report on Thursday. Piper Sandler increased their target price on shares of KORU Medical Systems from $3.00 to $3.50 and gave the stock an “overweight” rating in a research note on Thursday. Finally, B. Riley started coverage on shares of KORU Medical Systems in a research report on Thursday, July 25th. They set a “buy” rating and a $4.00 price target for the company.
View Our Latest Stock Analysis on KORU Medical Systems
KORU Medical Systems Stock Performance
Hedge Funds Weigh In On KORU Medical Systems
A number of institutional investors have recently made changes to their positions in KRMD. Aaron Wealth Advisors LLC purchased a new stake in KORU Medical Systems during the second quarter valued at about $28,000. Allspring Global Investments Holdings LLC bought a new stake in KORU Medical Systems in the 2nd quarter worth approximately $28,000. Legato Capital Management LLC purchased a new stake in KORU Medical Systems in the second quarter worth approximately $35,000. Virtu Financial LLC purchased a new position in shares of KORU Medical Systems during the first quarter worth approximately $63,000. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of KORU Medical Systems in the 2nd quarter worth approximately $107,000. Institutional investors own 58.60% of the company’s stock.
About KORU Medical Systems
KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.
Read More
- Five stocks we like better than KORU Medical Systems
- The 3 Best Fintech Stocks to Buy Now
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- How to Evaluate a Stock Before Buying
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- The Significance of Brokerage Rankings in Stock Selection
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for KORU Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KORU Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.